$MIRA Cashflow Statement | Understand Stock

$MIRA

$0.57 +$0.02 (2.79%) Close

Financial Statements

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operations
Non-cash interest expense
Amortization of debt issuance costs
Stock-based compensation expense
Non-cash warrant expense
Non-cash investor relations fees
Unrealized loss on short-term investments
Change in operating assets and liabilities:
Right of use lease, net
Prepaid expenses
Accounts receivable
Related party line of credit
Other receivables
Trade accounts payable and accrued expenses
Related party accrued interest
Net cash used in operating activities
Financing activities:
Offering costs
Repayments under related party line of credit
Advances received from related party line of credit
Proceeds from related party
Proceeds from Common stock option exercises
Advances from (to) affiliates
Bayshore Trust short-swing disgorgement
Net proceeds
Net cash provided by financing activities
Net increase (decrease) in cash
Cash, beginning of year
Cash, end of year
Supplemental schedule of non-cash financing activities:
Deferred offering costs charged to additional paid-in capital
Issuance of common stock for the short-term investments, SKNY acquisition

Comments